AstraZeneca Halts Investment Amid UK Pharma Challenges
Published on: Sept. 12, 2025, 11:26 p.m. | Source: Devdiscourse
AstraZeneca has paused a significant £200 million investment in its Cambridge research site, impacting planned job creation. This follows the abandonment of a £450 million investment in northern England and highlights wider concerns about the UK's business climate for pharmaceutical companies.
